Explore Pain Management Therapeutics Market: Valued at $73.6 Billion in 2021, Projected CAGR of 2.9% till 2031 (TMR Report)

Significant usage of pain management drugs, especially prescriptive medications such as non-steroidal anti-inflammatory drugs (NSAIDs), is anticipated to propel the marketWilmington, Delaware, United States, Aug. 14, 2023 (GLOBE NEWSWIRE) -- Transparency Market Research Inc. - The global pain management therapeutics market was valued at US$ 73.6 Bn in 2021 and is projected to surpass US$ 98.0 Bn by 2031. Extensive research in personalized pain management for chronic pain in the past few years ha

Related Keywords

China ,India ,Delaware ,United States ,Japan ,Canada ,America ,Asia Pacific ,Nikhil Sawlani ,Purdue Pharma ,Depomed Inc ,Merck Co ,Transparency Market Research Inc ,Route Of Administration ,Teva Pharmaceutical Industries Ltd ,Merck Co Inc ,Endo International ,Transparency Market Research ,Johnson ,Mallinckrodt Pharmaceuticals ,Venus Remedies ,Cq Biomed Inc ,Pfizer Inc ,Glaxosmithkline ,Astrazeneca ,Market Research ,Business Strategy ,Market Intelligence ,Request Your Free Sample Copy Now ,Middle East ,Venus Remedies Limited ,In Depth Competitive Analysis ,Buy Now ,Growth Drivers ,Pain Management Therapeutics ,Canada Toll Free ,Pain Management ,Chronic Pain ,Market Development ,Market Size ,Glaxosmithkline Plc ,North America ,